181
Views
27
CrossRef citations to date
0
Altmetric
Articles

Copper(II) and molybdenum(VI) complexes with 5-bromosalicylaldehyde S-allylisothiosemicarbazone: Syntheses, characterizations and crystal structures

, , &
Pages 345-357 | Received 17 Jun 2012, Accepted 20 Sep 2012, Published online: 23 Jan 2013
 

Abstract

A new tridentate Schiff base, 5-bromosalicylaldehyde S-allylisothiosemicarbazone hydrobromide (H2L), and several new mononuclear complexes of copper(II) and molybdenum(VI) of this ligand with general formulas ([Cu(L)Im] (1)), ([Cu(L)NH3]·4H2O (2)), and ([MoO2(L)1-MeIm] (3), Imidazole: Im, 1-methylimidazole: 1-MeIm) were prepared and characterized by elemental analyses, IR, proton magnetic resonance Spectroscopy, and ultraviolet–visible techniques. The physico-chemical results suggested that the H2L coordinates in the dianionic tridentate form. Crystal structures of the Cu(II) complexes reveal a square planar configuration surrounded by the dianionic tridentate isothiosemicarbazone (ONN) and Im and NH3 for 1 and 2, respectively. The L2-, two oxo, and 1-methylimidazole are coordinated to molybdenum(VI) in a distorted octahedral geometry in 3. Formation of pure metal oxide residues was confirmed by thermal degradation of the complexes.

Acknowledgements

Reza Takjoo would like to thank the Ferdowsi University of Mashhad for supporting this work. We thank the Università di Messina (Italy) for the provision of a diffractometer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.